Clinical Trials Directory

Trials / Completed

CompletedNCT05725122

Stone Clearance in Patients With Upper Ureteric Stones Using Extracorporeal Shock Wave Lithotripsy Compared With Extracorporeal Shock Wave Lithotripsy Combined With Tamsulosin Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
82 (actual)
Sponsor
Services Hospital, Lahore · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Extracorporeal shock wave lithotripsy (ESWL) is the least invasive and effective treatment for upper ureteric stones with a stone clearance rate of 60-90%. Tamsulosin is an alpha-blocker widely used in urological practice to relax smooth muscle of the prostate and bladder neck. Its role as part of medical expulsion therapy for the treatment of patients with kidney and ureteric stones has proved to be of considerable success. However, its role in clearing upper ureteric stones as an adjunct to ESWL is controversial. Therefore, this study will be conducted to evaluate its role in stone clearance along with extracorporeal shock wave lithotripsy in patients with upper ureteric stones

Conditions

Interventions

TypeNameDescription
PROCEDUREExtracorporeal shock wave lithotripsyExtracorporeal shock wave lithotripsy will given to the patients
PROCEDUREExtracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy.Extracorporeal Shock Wave Lithotripsy combined with Tamsulosin Therapy will be given to the patients

Timeline

Start date
2018-02-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2023-02-13
Last updated
2023-02-13

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05725122. Inclusion in this directory is not an endorsement.